Ask Warren

Remed

302550 · KOSDAQ · ₩302550 · 리메드

₩2,215▼ ₩80 (3.49%)End-of-day · Oct 29, 2026 · End-of-day prices.
Trade
Alert me
SellBuy

Filings

  • 5%+ holding report주식등의대량보유상황보고서(일반)

    Predicted impact: Low

    Oct 30, 2026Open on DART
  • Amended: Convertible bond issue decision[기재정정]주요사항보고서(전환사채권발행결정)

    Predicted impact: Low

    Oct 27, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)

    Predicted impact: Low

    Oct 20, 2026Open on DART
  • Share cancellation decision주식소각결정

    Predicted impact: Medium

    Share cancellation of about ₩1.9B, roughly 2.6% of market value, already announced in recent items.

    Oct 19, 2026Open on DART
  • Amended: Convertible bond issue decision[기재정정]주요사항보고서(전환사채권발행결정)

    Predicted impact: Low

    Oct 19, 2026Open on DART
  • Trading Plan Report for Executives and Major Shareholders' Specific Securities임원ㆍ주요주주특정증권등거래계획보고서

    Predicted impact: Low· Actual: +0.9% vs sector, volume 0.7× normal (5 trading days)

    Oct 14, 2026Open on DART
  • Convertible bond issue decision주요사항보고서(전환사채권발행결정)

    Predicted impact: Medium· Actual: +0.9% vs sector, volume 0.7× normal (5 trading days)

    Convertible bond issue; size not stated, so likely meaningful but below the 5% share threshold.

    Oct 14, 2026Open on DART
  • Amended: Major sales or supply contract[기재정정]단일판매ㆍ공급계약체결Sep 29, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Sep 23, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Sep 18, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Sep 9, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Aug 26, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Aug 20, 2026Open on DART
  • Added attachment: Half-year report (Jun 2026)[첨부추가]반기보고서 (2026.06)Aug 12, 2026Open on DART
  • Buyback trust contract signed주요사항보고서(자기주식취득신탁계약체결결정)Aug 4, 2026Open on DART
  • Trust Contract Termination Result Report신탁계약해지결과보고서Aug 3, 2026Open on DART
  • Material Matters Report (Decision on Termination of Trust Agreement for Own Share Acquisition)주요사항보고서(자기주식취득신탁계약해지결정)Aug 3, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jul 30, 2026Open on DART
  • Share cancellation decision주식소각결정Jul 23, 2026Open on DART
  • Amended: Annual report (Dec 2025)[기재정정]사업보고서 (2025.12)Jun 26, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jun 24, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Jun 10, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)May 28, 2026Open on DART
  • Buyback trust contract signed주요사항보고서(자기주식취득신탁계약체결결정)May 20, 2026Open on DART
  • Trust Contract Termination Result Report신탁계약해지결과보고서May 20, 2026Open on DART
  • Material Matters Report (Decision on Termination of Trust Agreement for Own Share Acquisition)주요사항보고서(자기주식취득신탁계약해지결정)May 20, 2026Open on DART
  • Quarterly report (Mar 2026)분기보고서 (2026.03)May 14, 2026Open on DART
  • Status Report on Acquisition Under Trust Agreement신탁계약에의한취득상황보고서May 13, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)May 4, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Apr 29, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Apr 10, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Apr 10, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Apr 3, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Mar 27, 2026Open on DART
  • Report on Appointment, Dismissal, or Mid-Term Resignation of Independent Directors독립이사의선임ㆍ해임또는중도퇴임에관한신고Mar 27, 2026Open on DART
  • Annual general meeting results정기주주총회결과Mar 26, 2026Open on DART
  • Notice on Grant of Stock Purchase Options주식매수선택권부여에관한신고Mar 26, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Mar 19, 2026Open on DART
  • Audit report submitted감사보고서제출Mar 17, 2026Open on DART
  • Added attachment: Annual report (Dec 2025)[첨부추가]사업보고서 (2025.12)Mar 17, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Mar 12, 2026Open on DART
  • Reference Document for Proxy Solicitation of Voting Rights의결권대리행사권유참고서류Mar 10, 2026Open on DART
  • Notice of shareholders' meeting주주총회소집공고Mar 10, 2026Open on DART
  • Shareholders' meeting called주주총회소집결의Mar 9, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Mar 3, 2026Open on DART
  • 5%+ holding report주식등의대량보유상황보고서(일반)Feb 26, 2026Open on DART
  • Change in Revenue or Profit/Loss Structure of 30% or More (15% or More for Large Companies)매출액또는손익구조30%(대규모법인은15%)이상변동Feb 25, 2026Open on DART
  • Share cancellation decision주식소각결정Feb 9, 2026Open on DART
  • Buyback trust contract signed주요사항보고서(자기주식취득신탁계약체결결정)Feb 9, 2026Open on DART
  • Insider shareholding report임원ㆍ주요주주특정증권등소유상황보고서Feb 5, 2026Open on DART

Titles in Korean until English translations are added.

Also known as: Remed / 리메드 / 302550 / KRX:302550

Source: KRX statistical information